The Lung Immune Prognostic Index (LIPI) stratifies prognostic groups in advanced non-small cell lung cancer (NSCLC) patients

Transl Lung Cancer Res. 2020 Aug;9(4):967-970. doi: 10.21037/tlcr.2020.04.14.

Authors

Mihaela Aldea¹, Jose Carlos Benitez¹, Laura Mezquita^{1

2

3}

Affiliations

¹ Medical Oncology Department, Gustave Roussy, Villejuif, France.
² Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
³ Medical Oncology Department, Hospital Clínic, Barcelona, Spain.

No abstract available

Publication types

Editorial
Comment